Professional Documents
Culture Documents
Severely injured patients undergoing damage-control laparotomy (DCL) have multiple risk factors for adult respiratory distress
syndrome (ARDS), making it challenging to differentiate the contributions of individual causative factors. We aimed to
determine the relative contributions of ARDS risk factors.
METHODS:
Analysis of the prospectively collected American Association for the Surgery of Trauma Multi-institutional Open Abdomen
Database was performed. Inclusion criteria were any patient, 18 years or older, undergoing DCL at 1 of 14 participating Level I
trauma centers. Univariable and multivariable Cox regression analyses were performed to determine the association of variables with the development of ARDS during hospitalization.
RESULTS:
A total of 563 patients (78% men; mean [SD] age, 40 [18] years) were identied, of whom 77 developed ARDS (14%). Overall
mortality was 23%, with a 39% mortality rate for ARDS patients. Univariable analysis demonstrated that Injury Severity Score
(ISS, 1.03; 95% condence interval [CI], 1.02Y1.05), intraoperative (IO) estimated blood loss (hazard ratio [HR], 1.09; 95%
CI, 1.04Y1.13), IO plasma transfusion (HR, 1.17; 95% CI, 1.10Y1.25), 24-hour colloid volume (HR, 1.07; 95% CI, 1.04Y1.10),
and 24-hour crystalloid volume (HR, 1.01; 95% CI, 1.00Y1.01) were associated with the development of ARDS. Cox
multivariable analysis demonstrated that ISS, IO plasma transfusions, and total uid balance through 23 hours all increased the
risk of ARDS development.
CONCLUSION:
Severity of injury, plasma transfusions, and greater uid administration by 24 hours were independently associated with ARDS
development. Judicious use of plasma and other uids may reduce rates of ARDS in this critically injured population. (J Trauma
Acute Care Surg. 2014;77: 886Y891. Copyright * 2014 by Lippincott Williams & Wilkins)
LEVEL OF EVIDENCE: Prognostic study, level III; therapeutic study, level IV.
KEY WORDS:
Damage control; open abdomen; adult respiratory distress syndrome; trauma; laparotomy.
BACKGROUND:
886
most commonly applied procedure within the DCR management scheme.3Y6 These abbreviated laparotomies allow trauma
surgeons to gain source control of life-threatening injuries
while allowing for the delay in denitive treatment until
physiologic stabilization and subsequent reexploration. This
approach, hand in hand with the other DCR elements, remains
the standard of care for critically ill, unstable patients with
abdominal injuries.7
Despite demonstrated mortality benets with DCR
techniques, controversy remains. Integral in the counter argument to DCR is the potential three times greater risk of adult
respiratory distress syndrome (ARDS).8,9 This syndrome,
characterized by a profound dysfunction of gas exchange at the
alveoli secondary to inammation, can occur in up to 8.4% of
patients undergoing MT, with an associated 17% mortality in
severely injured patients.2,9 The etiology of ARDS in this
critically ill patient population remains elusive and is likely
multifactorial.10 The combination of phenotypic, environmental, and clinical hits have been implicated in ARDS
development. These hits are both inherent to the patient (genetic predisposition, injury severity, preexisting lung disease,
advanced age, ischemia/reperfusion) and potentially modiable by the clinician (i.e., fraction of inhaled oxygen [FIO2],
J Trauma Acute Care Surg
Volume 77, Number 6
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Zielinski et al.
except plasma, PRBC, platelets, or cryoprecipitate. Total colloid uid refers to the combination of nonblood colloids plus
blood product.17Y19
Descriptive statistics are reported as n (%) or as mean (SD)
as appropriate. Patients were assessed for the development of
ARDS following up a patient to either the postoperative day
(POD) of ARDS diagnosis (event) or the POD of hospital discharge (censor). The Cox proportional hazards model was used to
assess risk factors for association with ARDS. Variables known at
baseline, patient characteristics, organ injury and operative
intervention pattern, and intraoperative (IO) resuscitation characteristics were examined in all 563 patients. Resuscitation
characteristics through 24 hours were examined in the 510 patients still followed up at the end of POD 1, excluding patients
who died through POD 1 or those who had ARDS diagnosed by
POD 1. Similarly, resuscitation characteristics through 48 hours
were examined in the 480 patients still followed up at the end of
POD 2. All models included a variable for the medical center in
the study; therefore, a univariate model is a model containing a
class variable for medical centers and one additional variable of
interest. The medical center was included to account for possible
differences in practice between medical centers. A multivariable
model was examined for the 510 patients still followed up at the
end of POD 1. Patient characteristics and resuscitation characteristics known through POD 1 with a univariate signicance of
0.2 or less were examined. A backward selection method was
used retaining variables with signicance less than 0.05. The
> level was set at 0.05 for statistical signicance.
RESULTS
In total, 563 patients were in the AAST Open Abdomen
Database, of whom 77 (14%) developed ARDS. There was no
signicant association of either age or sex with the risk of
developing ARDS (Table 1). Univariable analysis demonstrated that a greater Injury Severity Score (ISS), Abbreviated
Injury Scale (AIS) score, and lower pH value were associated
with an increased risk of ARDS development. In addition,
ARDS was associated with a prolonged intensive care unit stay
when all deaths were excluded (28.5 [17.7] days vs. 16.0 [14.0]
days, p G 0.001). The same held true for hospital length of stay
when excluding all deaths (41.5 [23.8] vs. 24 [24.8], p G 0.001).
Age, y
Male sex
ISS
Head AIS score
Abdomen AIS score
Chest AIS score
Hemoglobin, g/dL
Lowest pH
Hypothermia (G35-C)
No ARDS (n = 486)
ARDS (n = 77)
HR (95% CI)
HR (95% CI)
39.7 (17.4)
375 (77.2%)
27.9 (13.2)
1.1 (1.7)
3.5 (1.1)
2.2 (1.6)
11.5 (3.1)
7.1 (0.8)
161 (33.1%)
43.0 (18.9)
62 (80.5%)
35.1 (14.5)
1.8 (1.8)
3.8 (0.9)
2.8 (1.4)
11.6 (3.2)
7.1 (0.1)
28 (36.4%)
1.12A (0.99Y1.27)
1.09 (0.62Y1.92)
1.03B (1.02Y1.05)
1.26B (1.11Y1.43)
1.42B (1.12Y1.80)
1.26B (1.08Y1.47)
1.00B (0.92Y1.08)
1.00B (0.74Y1.35)
1.33 (0.84Y2.12)
0.062
0.765
G0.001
G0.001
0.004
0.004
0.942
0.988
0.225
1.09 (0.95Y1.24)
1.07 (0.60Y1.90)
1.03 (1.01Y1.05)
1.16 (0.996Y1.34)
1.28 (0.995Y1.65)
1.19 (1.01Y1.40)
0.98 (0.90Y1.06)
0.97 (0.65Y1.45)
1.34 (0.83Y2.18)
0.221
0.812
G0.001
0.056
0.055
0.041
0.629
0.885
0.230
Continuous variables are provided as HR with 95% CI for Cox regression and as means (SD) for the descriptive statistics.
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
887
Zielinski et al.
DISCUSSION
DCR techniques, despite their benecial associations
with mortality, have signicant limitations. Similarly, DCL, as
an integral portion of DCR, has substantial drawbacks including
enterocutaneous stulae, sepsis, and ARDS.2,8,20 These complications, however, can only develop if the patient survives the
initial hemorrhagic event. Therefore, the real risk of death
outweighs the theoretical risk of complications from DCL and
should be performed if indicated. Naturally, the intensive care
unit portion of the patients course is fraught with further
complications, stemming not only from the initial physiologic
insult but also from subsequent second hits, which have their
own associated complications.10 It is the summation of these
primary and secondary hits that place critically ill trauma patients at risk for ARDS.21,22
ARDS has its own related mortality independent of the
traumatic insult. In the current study, ARDS was associated
with a doubling in the risk of death. As such, the development
of ARDS should not be viewed as an inevitable disease process
but as a preventable complication with the use of risk mitigation strategies throughout the resuscitation phase. As demonstrated, increasing reliance on plasma and uids for
resuscitation promoted an increased risk of ARDS. The infusion of 10 L of uid (both crystalloid and blood products)
during the rst 24 hours after injury increased the risk of ARDS
development by an additional 10%.
This study is not unique in nding that uid administration
is associated with poor outcomes in signicantly injured patients.
IO
Estimated blood loss, L
Nonblood colloid, L
Total uid balance, L
PRBC volume, L
Plasma volume, L
Platelet volume, L
Plasma/PRBC, U
C/PRBC, U
24 h
Total colloid, L
Total crystalloid, L
Total uids, L
48 h
Total colloid, L
Total crystalloid, L
Total uids, L
No ARDS (n = 485)
ARDS (n = 77)
HR (95% CI)
HR (95% CI)
2.38 (3.22)
0.57 (1.26)
6.68 (13.75)
2.84 (7.27)
1.63 (2.06)
0.44 (0.98)
0.7 (0.5)
4.5 (6.5)
3.83 (5.39)
0.32 (0.55)
8.10 (7.96)
3.90 (3.86)
2.91 (3.39)
0.62 (1.00)
0.7 (0.5)
3.5 (5.9)
1.09 (1.04Y1.13)
0.70 (0.44Y1.11)
1.00 (0.99Y1.02)
1.01 (0.99Y1.03)
1.17 (1.10Y1.25)
1.14 (0.96Y1.35)
0.88A (0.54Y1.42)
1.40A (1.13Y1.72)
0.398
0.128
0.395
0.191
0.001
0.001
0.585
0.002
1.10 (1.05Y1.16)
0.77 (0.50Y1.20)
1.00 (0.99Y1.02)
1.01 (0.99Y1.03)
1.21 (1.12Y1.31)
1.13 (0.92Y1.38)
0.76 (0.43Y1.32)
0.96 (0.91Y1.00)
G0.001
0.250
0.524
0.245
G0.001
0.254
0.325
0.072
1.36 (3.02)
6.33 (8.70)
7.69 (9.51)
3.80 (7.33)
15.36 (54.59)
19.16 (57.65)
1.09 (1.05Y1.13)
1.01 (1.00Y1.01)
1.01 (1.00Y1.01)
G0.001
G0.001
G0.001
1.10 (1.05Y1.15)
1.005 (1.00Y1.01)
1.005 (1.001Y1.01)
G0.001
0.057
0.022
1.01 (2.91)
6.85 (7.94)
7.86 (9.04)
2.05 (5.42)
8.60 (6.94)
10.64 (10.59)
1.06 (1.00Y1.12)
1.03 (1.00Y1.05)
1.03 (1.01Y1.05)
0.034
0.058
0.016
1.10 (1.02Y1.19)
1.02 (0.99Y1.05)
1.03 (1.002Y1.05)
0.014
0.206
0.036
Continuous variables are provided as HR with 95% CI for Cox regression as well as means (SD) for descriptive statistics.
A
= Hazard Ratio based on smoothing spline result where values greater than 3 reset as equivalent to 3.
888
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Zielinski et al.
ARDS (n = 77)
HR (95% CI)
HR (95% CI)
178 (36.0)
140 (28.3)
115 (23.7)
109 (22.0)
77 (15.8)
57 (11.5)
57 (11.5)
33 (6.7)
36 (46.8)
19 (24.7)
20 (26.0)
11 (14.3)
13 (16.9)
14 (18.2)
8 (10.4)
3 (3.9)
1.46 (0.93Y2.29)
0.88 (0.52Y1.48)
1.10 (0.66Y1.84)
0.62 (0.33Y1.17)
1.01 (0.55Y1.83)
1.46 (0.82Y2.61)
0.86 (0.41Y1.79)
0.56 (0.18Y1.79)
0.097
0.624
0.705
0.142
0.984
0.198
0.684
0.331
1.37 (0.75Y2.52)
0.72 (0.34Y1.52)
1.49 (0.79Y2.80)
0.74 (0.33Y1.70)
0.87 (0.38Y1.96)
1.41 (0.62Y3.20)
1.57 (0.65Y3.78)
0.67 (0.16Y2.80)
0.304
0.381
0.218
0.482
0.732
0.417
0.318
0.585
5 (1.0)
30 (6.2)
15 (3.0)
2 (2.6)
8 (10.4)
2 (2.6)
3.29 (0.81Y13.42)
2.07 (1.00Y4.31)
1.25 (0.31Y5.11)
0.097
0.051
0.753
4.78 (0.63Y36.34)
1.64 (0.49Y5.44)
1.92 (0.25Y14.55)
0.131
0.421
0.527
Continuous variables are provided as HR 95% CI for Cox regression as well as means (SD) for descriptive statistics.
A greater crystalloid-to-PRBC (C/PRBC) ratio has been associated with multisystem organ failure, ARDS, and abdominal
compartment syndrome, although, interestingly, not death.11
This effect was dose responsive as a C/PRBC greater than 1.5:1
conferred a two times higher likelihood of developing ARDS.
Correspondingly, the PRospective Observational Multicenter
Major Trauma Transfusion (PROMMTT) study conrms that
chest injury severity, advanced age, and greater use of crystalloid
were independent risk factors for ARDS development.16 Our
study, however, also demonstrated that blood product administration, specically plasma, was associated with the ARDS risk
on multivariable analysis.
While transfusion-related ALI may no longer be a recognized entity, the risk of transfusion-associated ARDS cannot be
eliminated because of nomenclature alone. Previous reports in
similar patient populations have demonstrated an increased risk
of ARDS with blood product transfusions.23,24 These studies,
however, considered ARDS as an single end point rather than one
that evolves throughout hospitalization as a time-dependent
complication. More precisely, the current study allows for the
true analysis of ARDS risk factors over time. In addition, the
multi-institutional, prospective nature of the current study should
confer a wider applicability of these results.
The next evolution in hemorrhage resuscitation, representing the ultimate culmination of DCR techniques, is the
transfusion of whole blood. That crystalloid, rather than blood
products, increases the risk of ARDS makes intuitive sense.
HR (95% CI)
HR (95% CI)
1.03 (1.01Y1.05)
1.16 (1.07Y1.25)
1.010 (1.005Y1.014)
0.004
G0.001
G0.001
1.02 (1.002Y1.04)
1.17 (1.06Y1.28)
1.005 (1.001Y1.010)
0.031
0.001
0.028
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
889
Zielinski et al.
890
AAST database and contributed in the project idea development, manuscript review, and critical revision.
ACKNOWLEDGMENT
The AAST Open Abdomen Study group thanks the following individuals,
without whom this study could not have been completed: Mohammad
Alzghari, MBBS; Mahmoud A. Amr, MBBS; Meghan Spencer; Rebecca
Grace Lopez MS4; Jinfeng Han, BSN; Judith S. Katzen, MS, RN; Terry
Curry, RN; Sadia Ali, MPH; and Mary Waage.
AAST Open Abdomen Study Group Authors
In addition, we would like to acknowledge all participating members
and institutions included as authors in the AAST Open Abdomen Study
Group; Binod Shrestha, MD, and John Holcomb, MD, from the University of Texas Houston Medical Center; Kenji Inaba, MD, Obi Okoye,
MD, and Agathoklis Konstantinidis, MD, from the Los Angeles County +
University of Southern California Hospital; Tom Scalea, MD, Jay
Menaker, MD, and Joe DuBose, MD, from the R Adams Cowley Shock
Trauma Center, University of Maryland Medical Center; James F.
Whelan, MD, Rao Ivatury, MD, and Stephanie R. Goldberg, MD, from
the Virginia Commonwealth University; Martin D. Zielinski, MD, Donald
Jenkins, MD, Karla V. Ballman, PhD, and William S. Harmsen, from the
Mayo Clinic Trauma Centers; Stephen Rowe, MD, Darrell Alley, MD,
John Berne, MD, and LaDonna Allen, RN, from the East Texas Medical
Center; Paola G. Pieri, MD, and Starre Haney, RN, MS, from the
Maricopa Integrated Health System; Jeffrey A. Claridge, MD, and
Katherine Kelly, MD, from the MetroHealth Medical Center; Tiffany Bee,
MD, and Timothy Fabian, MD, from the University of Tennessee Health
Science Center; Raul Coimbra, MD, PhD, and Jay Doucet, MD, from the
University of California San Diego School of Medicine; Ben Coopwood,
MD, David Keith, MD, and Carlos Brown, MD, from the University of
Texas Southwestern-Austin, University Medical Center Brackenridge;
James M. Haan, MD, and Jeanette Ward, BA, from the Via Christi Hospital, St. Francis Campus; Stuart M. Leon, MD, Evert Eriksson, MD, and
Debbie Couillard, RN, BSN, from The Medical University of Southern
Carolina; and Marc A. de Moya, MD, and Gwendolyn M. van der
Wilden, MSc, from the Massachusetts General Hospital.
DISCLOSURE
The authors declare no conflicts of interest.
REFERENCES
1. Duchesne JC, McSwain NE Jr, Cotton BA, Hunt JP, Dellavolpe J, Lafaro
K, Marr AB, Gonzalez EA, Phelan HA, Bilski T, et al. Damage control
resuscitation: the new face of damage control. J Trauma. 2010;69(4):
976Y990.
2. Murad MH, Stubbs JR, Gandhi MJ, Wang AT, Paul A, Erwin PJ, Montori
VM, Roback JD. The effect of plasma transfusion on morbidity and
mortality: a systematic review and meta-analysis. Transfusion. 2010;50:
1370Y1383.
3. Rotondo MF, Schwab CW, McGonigal MD, et al. Damage control: an
approach for improved survival in exsanguinating penetrating abdominal
injury. J Trauma. 1993;35:375Y382; discussion 382Y373.
4. Lucas CE, Ledgerwood AM. Prospective evaluation of hemostatic techniques for liver injuries. J Trauma. 1976;16(6):442Y451.
5. Stone HH, Strom PR, Mullins RJ. Management of the major coagulopathy
with onset during laparotomy. Ann Surg. 1983;197:532Y535.
6. Hatch QM, Osterhout LM, Ashraf A, Podbielski J, Kozar RA, Wade CE,
Holcomb JB, Cotton BA. Current use of damage-control laparotomy,
closure rates, and predictors of early fascial closure at the rst take-back. J
Trauma. 2011;70(6):1429Y1436.
7. Dubose JJ, Scalea TM, Holcomb JB, Shrestha B, Okoye O, Inaba K, Bee
TK, Fabian TC, Whelan J, Ivatury RR; AAST Open Abdomen Study
Group. Open abdominal management after damage-control laparotomy for
trauma: a prospective observational American Association for the Surgery
of Trauma multicenter study. J Trauma Acute Care Surg. 2013;74(1):
113Y120; discussion 1120Y1122.
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
8. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory
distress in adults. Lancet. 1967;2:319Y323.
9. Park P, Cannon JW, Ye W, Blackbourne LH, Holcomb JB, Beninati W,
Napolitano LM. Transfusion strategies and development of acute respiratory distress syndrome in combat casualty care. J Trauma Acute Care
Surg. 2013;75(2 Suppl 2):S238YS246.
10. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions
in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med. 2003;167:1027Y1035.
11. Neal MD, Hoffman MK, Cuschieri J, Minei JP, Maier RV, Harbrecht BG,
Billiar TR, Peitzman AB, Moore EE, Cohen MJ, et al. Crystalloid to
packed red blood cell transfusion ratio in the massively transfused patient:
when a little goes a long way. J Trauma Acute Care Surg. 2012;72:
892Y898.
12. Gajic O, Rana R, Mendez JL, Rickman OB, Lymp JF, Hubmayr RD, Moore
SB. Acute lung injury after blood transfusion in mechanically ventilated
patients. Transfusion. 2004;44:1468Y1474.
13. Garcia JG, Moreno Vinasco L. Genomic insights into acute inammatory
lung injury. Am J Physiol Lung Cell Mol Physiol. 2006;291:L1113YL1117.
14. Cotton BA, Podbielski J, Camp E, Welch T, del Junco D, Bai Y, Hobbs R,
Scroggins J, Hartwell B, Kozar RA, et al.; Early Whole Blood
Investigators. A randomized controlled pilot trial of modied whole
blood versus component therapy in severely injured patients requiring
large volume transfusions. Ann Surg. 2013;258(4):527Y532; discussion
532Y533.
15. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan
E, Camporota L, Slutsky AS, ARDS Denition Task Force. Acute respiratory distress syndrome: the Berlin Denition. JAMA. 2012;307(23):
2526Y2533.
16. Robinson BRH, Cotton BA, Pritts TA, Branson R, Holcomb JB, Muskat P,
Fox EE, Wade CE, del Junco DJ, Bulger EM, et al.; PROMMTT study
group. Application of the Berlin denition in PROMMTT patients: the
impact of resuscitation on the incidence of hypoxemia. J Trauma Acute
Care Surg. 2013;75(1):S61YS67.
17. Campion EM, Pritts TA, Dorlac WC, Nguyen AQ, Fraley SM, Hanseman
D, Robinson BRH. Implementation of a military-derived damage-control
resuscitation strategy in a civilian trauma center decreases acute hypoxia
in massively transfused patients. J Trauma Acute Care Surg. 75(2):
S221YS227.
Zielinski et al.
Copyright 2014 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
891